Pharma Market Access Insights - from Mtech Access

64 Epizód

1. Navigating US payer evidence needs to optimise market access

   Közzétéve: 2024. 11. 27.
2. Best practice RWE approaches to support economic modelling for HTA

   Közzétéve: 2024. 11. 20.
3. NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

   Közzétéve: 2024. 11. 18.
4. De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

   Közzétéve: 2024. 10. 11.
5. NHS primary care panel – the GP Contract and Operational Planning Guidance

   Közzétéve: 2024. 09. 10.
6. Engage NHS healthcare decision-makers with RWD

   Közzétéve: 2024. 08. 12.
7. Market access and reimbursement in Canada – changes at CADTH

   Közzétéve: 2024. 06. 20.
8. Rare Disease market access in the MENA and Nordic regions

   Közzétéve: 2024. 05. 10.
9. How does funding flow in NHSE Regions?

   Közzétéve: 2024. 04. 09.
10. NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

    Közzétéve: 2024. 04. 09.
11. De-mystifying health economic model classifications and structures

    Közzétéve: 2024. 03. 22.
12. Evidence strategy for Medical Technologies and Diagnostics

    Közzétéve: 2024. 03. 12.
13. How to set your Pharma or Medtech product up for success in the US market

    Közzétéve: 2024. 02. 26.
14. What's happening with specialised commissioning in the NHS?

    Közzétéve: 2024. 02. 12.
15. Integrated care in NHS Wales – what can England learn from its neighbour?

    Közzétéve: 2024. 01. 17.
16. Market access in Italy: Reforms at AIFA

    Közzétéve: 2023. 12. 18.
17. Unmet need in NHS primary care – How can industry best support PCN leaders?

    Közzétéve: 2023. 11. 28.
18. Population health management: a community effort across health and life sciences

    Közzétéve: 2023. 11. 01.
19. Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

    Közzétéve: 2023. 10. 26.
20. 6 areas of UK health policy for Medtech to pay attention to

    Közzétéve: 2023. 10. 16.